A Safety Study of LY2886721 Multiple Doses in Healthy Subjects
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
This is a Phase 1 study in healthy subjects to evaluate the safety and tolerability of
LY2886721 multiple doses, how the body handles the drug, and the drug's effect on the body.